Cell and Gene Manufacturing and Logistics

  1. IVGE Process And Optimization 5/29/2025

    Optimize your therapeutic protein's glycan profile. Learn about a straightforward, enzymatic approach to gain greater control over this critical quality attribute.

  2. Opening Possibilities In Glycosylation 5/29/2025

    Achieving desired glycosylation for therapeutic proteins can be difficult. Explore innovative approaches to optimize this critical quality attribute.

  3. Clues To Mapping A Crisis-Ready Tech Transfer Playbook 5/28/2025

    One of the many people behind AstraZeneca's COVID-19 response describes lessons learned during the biggest global health emergency of the modern era.

  4. How To Automate Bioprocesses Without Locking Out Future Upgrades 5/28/2025

    Introducing automation now means you limit your ability to upgrade later. Early attention could give you options when the next generation of technology rolls around.

  5. Cell Therapy Services: Customized Cell Collections 5/28/2025

    Ready to go deeper on cell characterization? Advance past typical cell and donor screening to create a comprehensive immune cell profile for each donor as well as an assessment of the metabolic and effector potential of their cells. See beyond surface markers too.

  6. Cell Therapy Services: Process Development And cGMP Manufacturing 5/28/2025

    Now that you have the best donated cellular material, it is time to optimize your cell therapy process for cGMP manufacturing. We offer R&D services including process development and cGMP production for Phase I through Commercial manufacturing.

  7. Cell Therapy Bioprocessing Workflow Cinematic 5/28/2025

    Witness a seamless cell therapy bioprocessing workflow that reduces manufacturing time and preserves the crucial cell phenotype for scalable, effective autologous and allogeneic therapies.

  8. Considerations For Tangential Flow Filtration Process Development 5/27/2025

    Optimize your TFF process with single-pass technology by joining experts Mike Dango and Michael Brauchle as they share key strategies for scalable, efficient filtration process development.

  9. Animal-Origin Free Peptones In Cell Culture Media For Viral Vaccine Manufacturing 5/27/2025

    Investigate the impact of peptone supplementation on adenovirus and VSV production, highlighting its potential to reduce serum dependency in cell culture media. 

  10. Ori Spotlight: Designing Scalable Cell Therapy Manufacturing From Day One (Part Two) 5/23/2025

    Aaron Vernon from Quell Therapeutics joins to explore building robust cell therapy manufacturing, focusing on overcoming bottlenecks, smart facility design, and the crucial role of digitalization.